Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Aneuploidy: cancer's fatal flaw?

Williams BR, Amon A.

Cancer Res. 2009 Jul 1;69(13):5289-91. doi: 10.1158/0008-5472.CAN-09-0944. Review.

2.

Cancer cells preferentially lose small chromosomes.

Duijf PH, Schultz N, Benezra R.

Int J Cancer. 2013 May 15;132(10):2316-26. doi: 10.1002/ijc.27924.

3.

Aneuploidy: cells losing their balance.

Torres EM, Williams BR, Amon A.

Genetics. 2008 Jun;179(2):737-46. doi: 10.1534/genetics.108.090878. Review.

4.

DNA content and chromosome number in twenty-five human carcinomas.

Paulete-Vanrell J.

Oncology. 1970;24(1):48-57. No abstract available.

PMID:
5416714
5.

The aneuploidy paradox in cell growth and tumorigenesis.

Weaver BA, Cleveland DW.

Cancer Cell. 2008 Dec 9;14(6):431-3. doi: 10.1016/j.ccr.2008.11.011.

6.

[Origin and role of aneuploidy in cancer].

Schnerch D, Hasskarl J, Engelhardt M, Wäsch R.

Dtsch Med Wochenschr. 2006 Aug 4;131(31-32):1747-53. German.

PMID:
16868879
7.

Is carcinogenesis a form of speciation?

Duesberg P, Mandrioli D, McCormack A, Nicholson JM.

Cell Cycle. 2011 Jul 1;10(13):2100-14.

PMID:
21666415
8.

Losing balance: the origin and impact of aneuploidy in cancer.

Holland AJ, Cleveland DW.

EMBO Rep. 2012 Jun 1;13(6):501-14. doi: 10.1038/embor.2012.55. Review.

9.

[Measurement of DNA content and analysis of chromosome using flow cytometry].

Akagi K, Uda M, Itagaki Y, Tanaka Y.

Gan No Rinsho. 1989 Oct;35(13):1559-65. Review. Japanese.

PMID:
2531240
10.

[Flow cytometric analysis of chromosome aberration on tumor cells].

Akagi K, Tanaka Y.

Nihon Rinsho. 1992 Oct;50(10):2489-96. Review. Japanese.

PMID:
1447821
11.

Large-scale analysis of chromosomal aberrations in cancer karyotypes reveals two distinct paths to aneuploidy.

Ozery-Flato M, Linhart C, Trakhtenbrot L, Izraeli S, Shamir R.

Genome Biol. 2011 Jun 29;12(6):R61. doi: 10.1186/gb-2011-12-6-r61.

12.

Causes and consequences of aneuploidy in cancer.

Gordon DJ, Resio B, Pellman D.

Nat Rev Genet. 2012 Jan 24;13(3):189-203. doi: 10.1038/nrg3123. Review.

PMID:
22269907
13.

A little CIN may cost a lot: revisiting aneuploidy and cancer.

Chandhok NS, Pellman D.

Curr Opin Genet Dev. 2009 Feb;19(1):74-81. doi: 10.1016/j.gde.2008.12.004. Review.

PMID:
19195877
14.

[Marker chromosomes in the karyotype of cells of the NK-Ly ascitic tumor].

Poroshenko GG, Nikol'skaia TA.

Dokl Akad Nauk SSSR. 1967 May 1;174(1):210-2. Russian. No abstract available.

PMID:
5622446
15.

Centrosomal abnormality is common in and a potential biomarker for bladder cancer.

Jiang F, Caraway NP, Sabichi AL, Zhang HZ, Ruitrok A, Grossman HB, Gu J, Lerner SP, Lippman S, Katz RL.

Int J Cancer. 2003 Sep 20;106(5):661-5.

16.

Destabilizing aneuploidy by targeting cell cycle and mitotic checkpoint proteins in cancer cells.

Colombo R, Moll J.

Curr Drug Targets. 2010 Oct;11(10):1325-35. Review.

PMID:
20840075
17.

Short- and long-term effects of chromosome mis-segregation and aneuploidy.

Santaguida S, Amon A.

Nat Rev Mol Cell Biol. 2015 Aug;16(8):473-85. doi: 10.1038/nrm4025. Review. Erratum in: Nat Rev Mol Cell Biol. 2015 Sep;16(9):576.

PMID:
26204159
18.

Chromosome alterations in cancer development and apoptosis.

Pathak S, Dave BJ, Gagos S.

In Vivo. 1994 Nov-Dec;8(5):843-50. Review.

PMID:
7727734
19.

Chromosomal chaos and cancer.

Duesberg P.

Sci Am. 2007 May;296(5):52-9. No abstract available.

PMID:
17500414
20.

Overexpressed pituitary tumor-transforming gene causes aneuploidy in live human cells.

Yu R, Lu W, Chen J, McCabe CJ, Melmed S.

Endocrinology. 2003 Nov;144(11):4991-8.

PMID:
12960092
Items per page

Supplemental Content

Support Center